Vulvar Lichen Sclerosus. The Skin Condition No One Talks About
Vulvar lichen sclerosus (VLS) is a chronic inflammatory skin condition that affects the vulva (external genital area) the skin around the vaginal entrance, clitoris, and anus. It causes white, crinkly patches, intense itching, and scarring that can narrow the vaginal opening and destroy normal anatomy.
Prevalence: Estimates range from 0.1–3% of adult women, with higher rates (up to 3%) in older women. It's vastly underdiagnosed many women suffer for years, mistaking it for yeast infections, eczema, BV, or "normal aging."
For BVTalks readers, VLS can coexist with BV or be misdiagnosed as infection. This guide covers symptoms, diagnosis, cancer risk, treatment, and self‑advocacy.
What Vulvar Lichen Sclerosus Looks Like
Classic appearance (not always visible early):
White, porcelain‑like patches on vulva/labia.
Crinkly/thin "cigarette paper" skin.
Bruising/purple spots (telangiectasia).
Scarring: Labia minora disappear, vaginal opening narrows ("pinpoint introital stenosis").
Early: Itching, mild white spots
Moderate: Crinkling, labia flattening
Advanced: Fusion, stenosis, clitoral hood scarring
Symptoms (Beyond What You See)
Most common:
Intense vulvar itching (day/night).
Burning/stinging after scratching.
Pain with sex/tampons (dyspareunia).
Soreness (clothes, sitting).
Advanced:
Constipation (anal scarring).
Urinary retention (urethral narrowing).
Sexual dysfunction (complete penetration impossible).
BV overlap: White patches + discharge can look like chronic yeast, but steroid cream, not antifungals, is treatment.
Who Gets Vulvar Lichen Sclerosus?
Demographics:
Postmenopausal women (peak incidence, up to 3%).
Premenopausal (15–30% cases).
Children (before puberty, rare but serious).
Family history increases risk (genetic component).
Risk factors:
Autoimmune diseases (thyroiditis 20–30% co‑occurrence).
Genetics (HLA association).
Trauma/infections may trigger.
NOT contagious autoimmune/skin disorder.
Cancer Risk: The Serious Complication
Vulvar squamous cell carcinoma risk:
2–5% lifetime risk in VLS patients.
11x higher than general population.
Early detection = 90%+ cure rate.
Warning signs:
Ulcer/growth in white patch.
Bleeding/persistent pain.
Thickened areas (different from usual).
Annual exams/biopsies recommended for advanced scarring.
Diagnosis: Why It Takes Years
Typical journey:
Self‑treat yeast (OTC antifungals fail).
GP: "Try hydrocortisone."
GYN: "Maybe BV/hormones."
Years later: Dermatologist/GYN specialist diagnoses via biopsy.
Gold standard: Punch biopsy of white patch confirms:
Epidermal thinning.
Dermal sclerosis.
Lymphocytic infiltrate.
Self‑advocacy phrase: "I've had chronic vulvar itching/scarring 2+ years despite antifungals/estrogen. Can we biopsy for lichen sclerosus?"
Treatment: Steroids Are King
Clobetasol propionate 0.05% ointment (ultra‑potent):
Apply thin layer daily x 3 months.
Then 2x/week maintenance lifelong.
80–90% response rate.
Month 1–3: Daily bedtime
Month 4–6: 2x/week
Lifelong: 1–2x/week or PRN flare
Adjuncts:
Emollients: Aquaphor/Vaseline (barrier).
Tacrolimus (if steroid‑resistant).
Surgery: Stenosis correction (post‑steroid control).
BV note: Treat co‑existing infections, but steroids first.
Daily Management
Must‑do habits:
Pat dry (no rubbing).
Cotton underwear, loose clothes.
Avoid irritants: Scented soap, pantyliners, latex condoms.
Cool packs for flares.
Sex:
Lidocaine 5% pre‑intercourse (20 min).
Lube + positions minimizing entry pressure.
Prognosis & Monitoring
With treatment:
90% symptom control.
Scarring doesn't reverse (prevent progression).
Lifelong condition (like diabetes).
Cancer surveillance:
Annual vulvar exam.
Biopsy suspicious areas immediately.
Frequently Asked Questions
Q: Can lichen sclerosus spread?
No autoimmune skin condition, not infection.
Q: Is it curable?
No lifelong management with steroids (like eczema/psoriasis).
Q: BV + lichen sclerosus together?
Yes white patches + discharge confusing. Biopsy clarifies.
Q: Children get it?
Yes (1–2% prepubertal girls). Resolves puberty or needs treatment.
Q: Self‑treat with steroids?
No prescription strength + monitoring needed.
Key Takeaways
VLS affects 0.1–3% women (higher in older women), vastly underdiagnosed.
White patches + itching + scarring = biopsy ASAP.
Clobetasol ointment = 90% effective (lifelong maintenance).
2–5% cancer risk annual exams essential.
Misdiagnosed as yeast/BV years advocate for biopsy.
Print/take to appointment: "Chronic vulvar itching/white patches despite antifungals. Can we biopsy for lichen sclerosus?"
References:
yalemedicine https://www.yalemedicine.org/conditions/lichen-sclerosus
pnc.ncbi.nim.nah https://pmc.ncbi.nlm.nih.gov/articles/PMC11122656/
jamanetwork https://jamanetwork.com/journals/jamadermatology/fullarticle/2836821
issupportnetwork https://lssupportnetwork.org/is-vulvar-lichen-sclerosus-rare-a-comprehensive-look-at-prevalence-burden-and-funding/
dynamed https://www.dynamed.com/condition/lichen-sclerosus-in-adults
About the Author
Becky Freeman is the founder of BVTalks® and Bee Vee Clean. She focuses on women’s intimate health, vaginal microbiome education, and creating practical, easy-to-understand content for everyday care.
Medical Disclaimer
This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any condition. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider if you have questions about your health or symptoms.
